Artificial intelligence continues to make headlines and dominates a lot of the discussions across the healthcare industry.
Vendors are certainly enthusiastic about the technology and its potential, which was apparent this week at the HLTH 2024 conference in Las Vegas.
Related: How 3 health systems decide when to buy or build AI
But health system executives are more cautious about the hype of AI. They are trying to understand the risks, opportunities and processes needed to adopt the technology. The cost of generative AI is increasingly a big consideration for many systems.
Here’s what executives at seven healthcare organizations said about where they stand with AI today. The responses have been edited for length and clarity.